FindTrial
Sign In

The use of urinary markers to improve adherence to the treatment of osteopoerosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN54722759
Enrollment
Unknown
Registered
2003-09-12
Start date
2002-11-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases: Osteoporosis Musculoskeletal Diseases Osteoporosis

Interventions

Urinary markers vs placebo Added July 2008: the trial was stopped due to lack of participants.

Sponsors

Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients starting drug therapy for treatment of osteoporosis.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

MeasureTime frame
Compliance to medication at 1 year, change in bone mineral density at 1 year.—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026